Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: A phase II trial

Lung Cancer ◽

10.1016/j.lungcan.2007.06.003 ◽

2007 ◽

Vol 58 (2) ◽

pp. 238-245 ◽

Author(s):

C. Pallarés ◽

J. Capdevila ◽

A. Paredes ◽

N. Farré ◽

J.P. Ciria ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Concurrent Radiotherapy ◽

Download Full-text

A phase II trial of induction chemotherapy followed by concomitant chemo-radiotherapy in stage IIIb non small cell lung cancer (NSCLC)

Lung Cancer ◽

10.1016/0169-5002(94)94475-x ◽

1994 ◽

Vol 11 ◽

pp. 181

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung

Download Full-text

S-1 Plus Cisplatin with Concurrent Radiotherapy for Locally Advanced Non-small Cell Lung Cancer: A Multi-Institutional Phase II Trial (West Japan Thoracic Oncology Group 3706)

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e3182307e5a ◽

2011 ◽

Vol 6 (12) ◽

pp. 2069-2075 ◽

Author(s):

Yukito Ichinose ◽

Takashi Seto ◽

Tomonari Sasaki ◽

Takeharu Yamanaka ◽

Isamu Okamoto ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Oncology Group ◽

Small Cell Lung ◽

Concurrent Radiotherapy

Download Full-text

Abstract CT041: Identification of gene signatures associated with response in a Phase II trial of entinostat (ENT) plus pembrolizumab (PEMBRO) in non-small cell lung cancer (NSCLC) patients whose disease has progressed on or after anti-PD-(L)1 therapy

10.1158/1538-7445.am2019-ct041 ◽

2019 ◽

Author(s):

Peter Ordentlich ◽

Lei Wang ◽

David Tamang ◽

Amy H. Sullivan ◽

Sally E. Church ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Gene Signatures ◽

Download Full-text

Randomised Phase II Trial of Oral Vinorelbine (N) and Cisplatin (P) or Pemetrexed and C (PC) in First Line Advanced Non Squamous (NSCC) Non Small Cell Lung Cancer (NSCLC) Patients (PTS). Navotrial01: Final Results

Annals of Oncology ◽

10.1016/s0923-7534(20)33841-2 ◽

2012 ◽

Vol 23 ◽

pp. ix409

Author(s):

E.H. Tan ◽

L. Havel ◽

M.J. Krzakowski ◽

J. Kollmeier ◽

R. Gervais ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Oral Vinorelbine ◽

Download Full-text

Phase II trial of Belagenpumatucel-L, a TGF-β2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients

Cancer Gene Therapy ◽

10.1038/cgt.2009.15 ◽

2009 ◽

Vol 16 (8) ◽

pp. 620-624 ◽

Author(s):

J Nemunaitis ◽

M Nemunaitis ◽

N Senzer ◽

P Snitz ◽

C Bedell ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Tumor Vaccine ◽

Small Cell Lung ◽

Antisense Gene ◽

Download Full-text

A phase II trial of induction chemotherapy followed by continuous hyperfractionated accelerated radiotherapy in locally advanced non-small cell lung cancer

Radiotherapy and Oncology ◽

10.1016/j.radonc.2010.03.011 ◽

2010 ◽

Vol 95 (2) ◽

pp. 258

Author(s):

Gianpiero Catalano ◽

Gaia Piperno ◽

Roberto Orecchia

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Small Cell Lung ◽

Accelerated Radiotherapy

Download Full-text

Docetaxel and cisplatin as induction chemotherapy in stage IIIA N2 non-small cell lung cancer (NSCLC): An EORTC phase II trial (08984)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.7166 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7166-7166 ◽

Author(s):

C. Manegold ◽

B. Biesma ◽

H. Smit ◽

J. Van Meerbeeck ◽

C. Debruyne ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Download Full-text

Sequential vinorelbine (V) and docetaxel (D) in advanced non-small cell lung cancer (NSCLC) patients age > 70, or with performance status (PS) 2: A SWOG phase II trial (S0027)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.7056 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7056-7056 ◽

Author(s):

P. J. Hesketh ◽

K. Chansky ◽

D. H. Lau ◽

J. Crowley ◽

D. R. Gandara

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Performance Status ◽

Small Cell Lung ◽

Download Full-text

Phase II trial with carboplatin/gemcitabine (Cb/G) induction chemotherapy (CT) followed by radiotherapy concomitantly with paclitaxel/gemcitabine (P/G) in stage III non small cell lung cancer (NSCLC): Preliminary report

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.7122 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7122-7122

Author(s):

V. Hirsh ◽

M. Duclos ◽

P. Del Vecchio ◽

L. M. Ofiara ◽

J. P. Ayoub ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Phase Ii ◽

Cell Lung Cancer ◽

Preliminary Report ◽

Phase Ii Trial ◽

Stage Iii ◽

Small Cell Lung

Download Full-text

Phase II trial of irinotecan and cisplatin with concurrent radiotherapy in limited-disease small cell lung cancer

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.7167 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7167-7167

Author(s):

J. Sohn ◽

Y. W. Moon ◽

C. G. Lee ◽

G. E. Kim ◽

K. Y. Chung ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Limited Disease ◽

Concurrent Radiotherapy

Download Full-text